Baillie Gifford & Co’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-733,525
| Closed | -$1.21M | – | 523 |
|
|
2022
Q1 | $1.21M | Buy |
733,525
+12,013
| +2% | +$19.8K | ﹤0.01% | 270 |
|
|
2021
Q4 | $1.72M | Buy |
721,512
+62,285
| +9% | +$149K | ﹤0.01% | 268 |
|
|
2021
Q3 | $3.6M | Buy |
659,227
+766
| +0.1% | +$4.18K | ﹤0.01% | 263 |
|
|
2021
Q2 | $4.9M | Buy |
658,461
+1,070
| +0.2% | +$7.96K | ﹤0.01% | 258 |
|
|
2021
Q1 | $5.33M | Buy |
657,391
+217,391
| +49% | +$1.76M | ﹤0.01% | 250 |
|
|
2020
Q4 | $4M | Hold |
440,000
| – | – | ﹤0.01% | 235 |
|
|
2020
Q3 | $4.87M | Hold |
440,000
| – | – | ﹤0.01% | 222 |
|
|
2020
Q2 | $3.27M | Hold |
440,000
| – | – | ﹤0.01% | 214 |
|
|
2020
Q1 | $2.71M | Hold |
440,000
| – | – | ﹤0.01% | 192 |
|
|
2019
Q4 | $2.21M | Hold |
440,000
| – | – | ﹤0.01% | 200 |
|
|
2019
Q3 | $3.31M | Hold |
440,000
| – | – | ﹤0.01% | 198 |
|
|
2019
Q2 | $5.1M | Hold |
440,000
| – | – | 0.01% | 200 |
|
|
2019
Q1 | $6.38M | Buy |
+440,000
| New | +$6.38M | 0.01% | 196 |
|